BlueCrest Capital Management’s Surgery Partners SGRY Stock Holding History

BlueCrest Capital Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,941	Closed	-$157K	–	1617
2017 Q4	$157K	Buy	+12,941	New	+$124K	﹤0.01%	733

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.57B AUM 19.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

BlueCrest Capital Management's SGRY Position: Q1 2018 in Review

BlueCrest Capital Management sold out of Surgery Partners (SGRY) in Q1 2018, closing a stake of 12,941 shares — an estimated $157K sold.

BlueCrest Capital Management first reported a position in SGRY in Q4 2017 and held it in 1 quarter. The position peaked at $157K in Q4 2017. 83 funds tracked by Wall St. Rank hold SGRY as of Q1 2018.

BlueCrest Capital Management reported no remaining Surgery Partners position as of Q1 2018 after selling out during the quarter.
BlueCrest Capital Management sold 12,941 Surgery Partners shares in Q1 2018, an estimated $157K.
BlueCrest Capital Management first reported a position in Surgery Partners in Q4 2017 and held it in 1 quarter.
BlueCrest Capital Management's Surgery Partners position peaked at $157K in Q4 2017.
83 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2018.

Based on BlueCrest Capital Management's 13F filing for Q1 2018, filed 15 May 2018.